CARPASCIO

CD19-directed chimeric antigen receptor T-cell therapy · Baylor College of Medicine

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CARPASCIO, covering 2025-11-14 to 2025-11-14. Get the full timeline:

Most recent: Clinical Trial Update: Activated T Lymphocytes Expressing CARs, Relapsed CD19+ Malignancies Post-Allo HSCT(CARPASCIO) [Phase 1]